designing a novel multi-epitope dna- based vaccine against tuberculosis: in silico approach

Authors

jale moradi department of microbiology, school of medicine, tehran university of medical sciences, tehran, ir iran

mina tabrizi department of medical genetics, school of medicine, tehran university of medical sciences, tehran, ir iran

maryam izad department of immunology, school of medicine, tehran university of medical sciences, tehran, ir iran

nader mosavari department of tuberculosis, razi vaccine and serum research institute, karaj, ir iran

abstract

conclusions the results revealed that the novel multi-epitope dna construct could be an effective candidate in tuberculosis vaccine development, and it is qualified to investigate its potential to induce cd4 and cd8 t- cell immune response in the experimental animal model. results mhc class i-and class ii-predicted epitopes showed a high potential to binding to human hlas alleles, with global broad-spectrum population coverage. the construct had no allergenicity, and the analysis indicated a desirable antigenicity of the construct. the construct had several posttranslational modifications, no signal peptide, and cytoplasmic localization with high score. also, mrna analysis showed low ∆g which demonstrated high stability and efficient translation. background tuberculosis remains a major global threat. two billion of the world’s population is latently infected with mycobacterium tuberculosis and is at the risk of progression to active disease. bacillus calmette-guerin (bcg), as the only licensed vaccine, has prophylaxis strategy, which protects children from disseminated form of tuberculosis. therefore, postexposure vaccine strategy, which targets individuals with latent tuberculosis infection, is an important strategy to control this disease globally. methods a mouse construct was designed based on predicted mhc class i-and class ii-restricted t- cell epitopes that fused together tandemly. mhc class i-and class ii-restricted epitopes were linked by aay and gpgpg motifs, respectively. lc3 directly fused to the mhc class ii-restricted epitopes at the c-terminus of the peptide. the varieties of expressed construct features were analyzed by bio- informatics tools. finally, construct codons were optimized and mrna structure of optimized construct was analyzed. objectives in the present study, we designed a novel postexposure multi-epitope dna construct based on 3 latency-associated antigens of rv2029c, rv2031c, and rv2627c and microtubule-associated protein light chain 3 (lc3) as a hallmark protein of the autophagy system.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

A Novel Multi-Epitope Vaccine For Cross Protection Against Hepatitis C Virus (HCV): An Immunoinformatics Approach

Background: Hepatitis C virus (HCV) causes acute and chronic human hepatitis infections. Due to the high genetic diversity and high rates of mutations in the genetic material so far there is no approved vaccine against HCV. Materials and Methods: The aim of this study was to determination B and T cell conserved epitopes of E1 and E2 proteins from HCV and construction of a chimeric pepti...

full text

Structure Evaluation of IroN for Designing a Vaccine against Escherichia Coli, an In Silico Approach

Introduction: Some strains of Escherichia Coli, including intestinal pathogenic strains, commensal strains, and extra intestinal pathogenic E. coli (ExPEC) have a significant impact on human health status. A standard vaccine designed based on conserved epitopes can stimulate a protective immune response against these pathogens. Additionally, enhanced expression at the infection site as a pathog...

full text

Design of a Novel Recombinant Multi-Epitope Vaccine against Triple-Negative Breast Cancer

Background: Triple-negative breast cancer (TNBC) is determined by the absence of ERBB2, estrogen and progesterone receptors’ expression. Cancer vaccines, as the novel immunotherapy strategies, have emerged as promising tools   for treating the advanced stage of TNBC. The aim of this study was to evaluate Carcinoembryonic antigen (CEA), Metadherin (MTDH), and Mucin 1 (MUC-1) proteins as vaccine ...

full text

In silico design a multivalent epitope vaccine against SARS-CoV-2 for Iranian populations

Background: Due to high genetic variation in human leukocyte antigen )HLA( alleles, epitope-based vaccines don’t show equal efficacy in different human populations. therefore, we proposed a multi-epitope vaccine against SARS-CoV-2 for Iranian populations. Materials and Methods: For this purpose, the proteins without allergenicity and high antigenicity as well as conservancy level from SARS-CoV...

full text

Immunoinformatics Design of a Multi-epitope-based Vaccine Against Colorectal Cancer

Background: Bioinformatic approaches for designing vaccines have become a promising alternative to conventional methods. We herein designed a multi-epitope-based vaccine against colorectal cancer (CRC). Methods: Used peptides in the CRC vaccines were retrieved from databases of PubMed, Web of Science, Google Scholar, and Clinical trials. The adjuvants of Mycobacterial heparin-binding hemagglut...

full text

A novel formulation of Mtb72F DNA vaccine for immunization against tuberculosis

Objective(s): Mycobacterium tuberculosis (M. tuberculosis), an intracellular pathogen, causes 1.5 million deaths globally. Bacilli Calmette-Guérin (BCG) is commonly administered to protect people against M. tuberculosis infection; however, there are some obstacles with this first-generation vaccine. DNA vaccines, the third generation vaccines, can induce cellular immun...

full text

My Resources

Save resource for easier access later


Journal title:
jundishapur journal of microbiology

جلد ۱۰، شماره ۳، صفحات ۰-۰

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023